Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.

Li, Ming; Wang, Ying; Song, Yongsheng; Bu, Renge; Yin, Bo; Fei, Xiang; Guo, Qizhen; Wu, Bin

Li, Ming; Wang, Ying; Song, Yongsheng; Bu, Renge; Yin, Bo; Fei, Xiang; Guo, Qizhen; Wu, Bin.

Afiliação

Li M; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Wang Y; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Song Y; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Bu R; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Yin B; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Fei X; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Guo Q; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Wu B; 1 Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China ; 2 Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA ; 3 Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Chin J Cancer Res ; 26(4): 371-81, 2014 Aug.

Article em En | MEDLINE | ID: mdl-25232208

Palavras-chave

Clear cell renal cell carcinoma (ccRCC); DNA methyltransferase 1 (DNMT1); immunohistochemistry; siRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Chin J Cancer Res Ano de publicação: 2014 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google